Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.
Kooij G, Troletti CD, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, Gasperini C, Battistini L, de Vries HE, Serhan CN, Chiurchiù V.
Kooij G, et al. Among authors: chiurchiu v.
Haematologica. 2020 Aug;105(8):2056-2070. doi: 10.3324/haematol.2019.219519. Epub 2019 Nov 28.
Haematologica. 2020.
PMID: 31780628
Free PMC article.